Optimizing Drug Development: Harnessing the Sustainability of Pharmaceutical Cocrystals
Molecular Pharmaceutics · 2024
DOI: 10.1021/acs.molpharmaceut.4c00289 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Srinivasulu Aitipamula und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Sustainability for Chemicals, Energy and Environment (ISCE2), Agency for Science, Technology and Research (A*STAR), 1 Pesek Road, Jurong…. Hauptthemen laut MEDLINE: Crystallization, Drug Development. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 199 Literaturangaben. Gefördert von: Agency for Science, Technology and Research, University of Hyderabad, University of Alabama.
Abstract (Originalsprache)
Environmental impacts of the industrial revolution necessitate adoption of sustainable practices in all areas of development. The pharmaceutical industry faces increasing pressure to minimize its ecological footprint due to its significant contribution to environmental pollution. Over the past two decades, pharmaceutical cocrystals have received immense popularity due to their ability to optimize the critical attributes of active pharmaceutical ingredients and presented an avenue to bring improved drug products to the market. This review explores the potential of pharmaceutical cocrystals as an ecofriendly alternative to traditional solid forms, offering a sustainable approach to drug development. From reducing the number of required doses to improving the stability of actives, from eliminating synthetic operations to using pharmaceutically approved chemicals, from the use of continuous and solvent-free manufacturing methods to leveraging published data on the safety and toxicology, the cocrystallization approach contributes to sustainability of drug development. The latest trends suggest a promising role of pharmaceutical cocrystals in bringing novel and improved medicines to the market, which has been further fuelled by the recent guidance from the major regulatory agencies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Sustainability for Chemicals, Energy and Environment (ISCE2), Agency for Science, Technology and Research (A*STAR), 1 Pesek Road, Jurong Island, Singapore 627833, Republic of Singapore.
- Department of Chemistry & Biochemistry, The University of Alabama, Tuscaloosa, Alabama 35487, United States.
ORCID-Profile: Srinivasulu Aitipamula
Förderung
- Agency for Science, Technology and Research
- University of Hyderabad
- University of Alabama
Zitieren
APA
Aitipamula, S., & Bolla, G. (2024). Optimizing Drug Development: Harnessing the Sustainability of Pharmaceutical Cocrystals. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00289
Vancouver
Aitipamula S, Bolla G. Optimizing Drug Development: Harnessing the Sustainability of Pharmaceutical Cocrystals. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00289
BibTeX
@article{Aitipamula2024,
author = {Aitipamula, Srinivasulu and Bolla, Geetha},
title = {Optimizing Drug Development: Harnessing the Sustainability of Pharmaceutical Cocrystals},
journal = {Molecular Pharmaceutics},
year = {2024},
doi = {10.1021/acs.molpharmaceut.4c00289}
}
EUVIMED